Legislation to modify the federal antitrust exemption for healthand medical malpractice insurers "will have no significant effect"on premiums charged for private health insurance, the CongressionalBudget Office has determined.
"Based on information from the Justice Department, the FederalTrade Commission, the National Association of InsuranceCommissioners, consumer groups and private attorneys, CBO estimatesthat both of those effects would be very small, and thus thatenacting the legislation would have no significant effect on thepremiums that private insurers would charge for health insurance,"the agency reported.
The CBO also said that to the extent insurers would otherwiseengage in prohibited practices and be prevented from doing so byenactment of this bill, premiums might be lower.
Continue Reading for Free
Register and gain access to:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
